BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Brown University
Brown University
Memorial Sloan Kettering Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Daiichi Sankyo
Haihe Biopharma Co., Ltd.
Zhongnan Hospital
Yonsei University
M.D. Anderson Cancer Center
Jiangsu HengRui Medicine Co., Ltd.
Aadi Bioscience, Inc.
Virginia Commonwealth University
Regeneron Pharmaceuticals
Jiangsu HengRui Medicine Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital
Aprea Therapeutics
Akeso
Mario Negri Institute for Pharmacological Research
Peking Union Medical College Hospital
ARCAGY/ GINECO GROUP
Nykode Therapeutics ASA
Chinese PLA General Hospital
M.D. Anderson Cancer Center
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Imperial College London
Loyola University
Memorial Sloan Kettering Cancer Center
Charite University, Berlin, Germany
Nykode Therapeutics ASA
pharmaand GmbH
H. Lee Moffitt Cancer Center and Research Institute
ARCAGY/ GINECO GROUP
Ruhr University of Bochum
Xenetic Biosciences, Inc.
Northwestern University
Peking Union Medical College Hospital
Chipscreen Biosciences, Ltd.
University of Virginia
Eli Lilly and Company
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Vejle Hospital
Icahn School of Medicine at Mount Sinai
University College, London
University College, London
Pfizer
Masonic Cancer Center, University of Minnesota
Guangxi Medical University
EMD Serono
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center